Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 27 pages - $99
Dec 2010 - 38 pages - $2,000
Jan 2011 - 52 pages - $1,000
Nov 2010 - 143 pages - $1,495
Jun 2010 - 30 pages - $125
Oct 2009 - 30 pages - $995
Oct 2011 - 88 pages - $3,500
Apr 2011 - 951 pages - $4,995
Sep 2010 - 137 pages - $3,835
May 2008 - 70 pages - $1,999
Your selection
Browse By
- Industry sector
- Diagnostic
- Equipment supplies
- General supplies
- Health & Hygiene
- Medical device
- Nutrition
- Petcare
- Pharmaceutical
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us